Table 5. Beliefs about barriers to symptomatic presentation and cancer outcomes – aggregate scores.
|
Mean score out of 50 (95% CI) |
||
|---|---|---|
| Barriers to symptomatic presentation | Negative beliefs about cancer outcomes | |
| UK | 8.29 (7.87–8.72) | 11.14 (10.71–11.58) |
| England | 8.85 (8.33–9.38) | 10.75 (10.21–11.29) |
| Northern Ireland | 9.30 (8.75–9.86) | 11.93 (11.37–12.48) |
|
Wales |
9.21 (8.59–9.83) |
11.11 (10.55–11.68 |
| Denmark |
4.95 (4.59–5.31) |
12.66 (12.19–13.13) |
| Norway |
5.28 (4.90–5.66) |
9.72 (9.25–10.19) |
| Sweden |
5.29 (4.95–5.64) |
12.06 (11.63–12.52) |
| Australia | 5.92 (5.58–6.26) | 12.82 (12.38–13.25) |
| New South Wales | 6.65 (6.06–7.25) | 12.48 (11.72–13.23) |
|
Victoria |
6.52 (5.97–7.08) |
12.18 (11.49–12.87) |
| Canada | 6.52 (6.06–6.98) | 12.39 (11.84–12.93) |
Abbreviation: CI=confidence interval. Note: a higher score on barriers to symptomatic presentation indicates more barriers; a higher score on negative beliefs about cancer outcomes indicates more negative beliefs about cancer outcomes.
All means adjusted for age and sex.
Means for all UK countries combined, both Australian states combined and all Canadian provinces combined are weighted for unequal sampling fraction by country (UK), state (Australia) and province (Canada).
All means are weighted for different probabilities of selection by household size.